title: Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations.
abstract: Mucin expression was analysed, in relation to cell growth, in parental HT-29 cells and in two populations of mucus-secreting HT-29 cells selected by adaptation to methotrexate (HT29-MTX) or 5-fluorouracil (HT29-FU). These two populations express mature mucins that differ in their immunoreactivity to antibodies against gastric (HT29-MTX) or colonic mucins (HT29-FU). In the parental population, at late confluency, only very few cells produce mucins or the MUC1 glycoprotein, this being consistent with the low level of expression of the mRNAs corresponding to the MUC1 to MUC5C mucin genes. In the HT29-MTX and HT29-FU populations, the appearance of mucus droplets, as shown by histochemistry and immunofluorescence, starts a few days after confluency, progressively involving a greater proportion of cells and reaching a steady state at late confluency. The MUC1 glycoprotein appears earlier, already being detectable in preconfluent cells. Its distribution is restricted to the apical surface of the cells and is distinct from that of the mucus droplets. In both populations the growth-related levels of MUC1 mRNA are concordant with the apparent levels of expression of the MUC1 glycoprotein. The levels of MUC2, MUC3, MUC4 and MUC5C mRNAs differ from one population to another and, within each population, according to the stage of the culture. The highest levels of MUC2 and MUC4 mRNAs are found in the HT29-FU cells, whereas the highest levels of MUC3 and MUC5C are found in the HT29-MTX cells, suggesting that the differences observed in the mature mucins expressed by either population may be related to which MUC genes are expressed. In both populations significant or even high levels of MUC mRNAs are already present in early cultures, i.e. at a stage when the mature mucins are not yet detectable, suggesting that mucin maturation is a later event.
authors.affiliation: INSERM U178, Villejuif, France.
authors.forename: T
authors.initials: T
authors.lastname: Lesuffleur
authors.forename: N
authors.initials: N
authors.lastname: Porchet
authors.forename: J P
authors.initials: JP
authors.lastname: Aubert
authors.forename: D
authors.initials: D
authors.lastname: Swallow
authors.forename: J R
authors.initials: JR
authors.lastname: Gum
authors.forename: Y S
authors.initials: YS
authors.lastname: Kim
authors.forename: F X
authors.initials: FX
authors.lastname: Real
authors.forename: A
authors.initials: A
authors.lastname: Zweibaum
mesh_terms: D015152:Blotting, Northern; D002454:Cell Differentiation / Q000235:genetics; D002455:Cell Division / Q000235:genetics; D002460:Cell Line; D005455:Fluorescent Antibody Technique; D005472:Fluorouracil / Q000494:pharmacology; D005786:Gene Expression Regulation; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D009077:Mucins / Q000096:biosynthesis* / Q000235:genetics; D009093:Mucus / Q000378:metabolism; D010641:Phenotype; D012333:RNA, Messenger
chemical_list: D009077:Mucins; D012333:RNA, Messenger; D005472:Fluorouracil; D008727:Methotrexate